EnVoy-LAB is a UC Berkeley spin-out advancing next-generation production of life-saving medical radioisotopes. We develop novel cyclotron-based methods for producing Actinium-225 and Lead-212, two of the most promising isotopes for targeted alpha therapy. Our technologies enable decentralized, scalable, and high-purity isotope production using existing standard cyclotrons, increasing supply for transformative cancer treatments.
| Website | http://www.envoy-lab.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2025 |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular EnVoy-LAB employee's phone or email?
Candace Fleming is the CEO of EnVoy-LAB.
1 people are employed at EnVoy-LAB.
EnVoy-LAB is based in Berkeley, California.